Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The cost for a one-month supply of the drugs lowest dose (2.5 mg) recommended only as a starter dose went from $349 to $299, while the 5 mg dose went from $499 per month to $399
Long-Term Safety : While early results are promising, long-term safety and tolerability remain under investigation
BBB accredited only since mid-2025, with some active complaints and a "Not Rated" status
Both the Kidney Disease Improving Global Outcomes guidelines and American Diabetes Association Standards of Care recommend GLP1-RA as the preferred glucose lowering class for people with T2D and moderate to advanced CKD or ESRD because of their demonstrated cardiovascular benefits in people with T2D at high risk of cardiovascular disease, which includes CKD 13,14
US$ 20.39
US$ 20.95
US$ 25.32
US$ 27.47
